Oncotelic Therapeutics Showcased for Innovative Cancer and Rare Disease Pipeline
September 16, 2025 — Oncotelic Therapeutics featured in NetworkNewsWire for its innovative RNA-based and immunotherapy pipeline targeting cancers and rare diseases, led by CEO Dr. Vuong Trieu.